- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/86 - Oxygen atoms
Patent holdings for IPC class C07D 211/86
Total number of patents in this class: 158
10-year publication summary
|
16
|
11
|
15
|
24
|
11
|
6
|
8
|
12
|
4
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
12 |
| Shionogi & Co., Ltd. | 914 |
8 |
| Mitsui Chemicals Agro, Inc. | 93 |
7 |
| ViiV Healthcare Company | 146 |
6 |
| F. Hoffmann-La Roche AG | 7958 |
4 |
| Genentech, Inc. | 3742 |
4 |
| Epizyme, Inc. | 383 |
4 |
| Unichem Laboratories Limited | 90 |
4 |
| Oxular Acquisitions Limited | 21 |
4 |
| AstraZeneca AB | 3042 |
3 |
| Janssen Pharmaceuticals, Inc. | 399 |
3 |
| Syngenta Participations AG | 4970 |
3 |
| Nitto Denko Corporation | 7879 |
3 |
| Aerpio Therapeutics, Inc. | 24 |
3 |
| Apotex Inc. | 197 |
3 |
| Huscion Co., Ltd. | 10 |
3 |
| The Procter & Gamble Company | 22178 |
2 |
| Glaxosmithkline LLC | 566 |
2 |
| The Regents of the University of California | 18943 |
2 |
| Pfizer Inc. | 3322 |
2 |
| Other owners | 76 |